PRR14 Acts a Novel Oncogene Activating the PI3K Signal Pathway in Human Cutaneous Squamous Cell Carcinoma

Overview

Journal J Cancer

Specialty Oncology

Date 2023 Jun 16

PMID 37325059

Authors

Lili Zhang

Jie Yang

Zhoujing Ji

Jie Zhang

Shengju Yang

Affiliations

Soon will be listed here.

Abstract

Proline rich protein 14 (PRR14) is considered as a new component of the nuclear fiber layer, it may be a key molecule in mediating nuclear morphological changes and functional changes in tumorigenesis. But, it's still unclear in human cutaneous squamous cell carcinoma (cSCC). In the study, the expression profiles of PRR14 in patients with cSCC were investigated by immunohistochemistry (IHC), also the PRR14 expression in cSCC tissues were detected using the methods of real-time quantitative PCR (RT-qPCR) and Western blot; cell counting kit-8 (CCK-8) assay, wound healing assay, matrigel-based transwell assay and Annexin V-FITC and PI double-staining with flow cytometry assay were used to investigate the biological functions of PRR14 in A431 and HSC-1 cSCC cells. Overexpression of PRR14 in cSCC patients was reported firstly in this study and its high expression was related to differentiation, thickness and tumor node metastasis (TNM) stage of cSCC. PRR14 inhibition with RNA interfering (RNAi) method resulted in the suppression of cell proliferation, migration and invasion but promotion the apoptosis of cSCC cells, and upregulation of the protein phosphorylation levels of mammalian target of rapamycin (mTOR), phosphoinositide 3-kinase (PI3K) and Akt. The study shows PRR14 maybe an activator of cSCC carcinogenesis through PI3K/Akt/mTOR signal pathway, and it also maybe a prognostic factor and new therapeutical target for cSCC treatment.

References

Feng C, Zhang H, Zeng A, Bai M, Wang X . Tumor-Suppressive MicroRNA-216b Binds to TPX2, Activating the p53 Signaling in Human Cutaneous Squamous Cell Carcinoma. Mol Ther Nucleic Acids. 2020; 20:186-195. PMC: 7068200. DOI: 10.1016/j.omtn.2020.01.022. View

Deng X, Zhen P, Niu X, Dai Y, Wang Y, Zhou M . APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma. J Dermatol Sci. 2020; 100(1):67-74. DOI: 10.1016/j.jdermsci.2020.08.012. View

Li S . Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J. 2005; 390(Pt 3):641-53. PMC: 1199657. DOI: 10.1042/BJ20050411. View

Schuller A, Wojtynek M, Mankus D, Tatli M, Kronenberg-Tenga R, Regmi S . The cellular environment shapes the nuclear pore complex architecture. Nature. 2021; 598(7882):667-671. PMC: 8550940. DOI: 10.1038/s41586-021-03985-3. View

Yang M, Lewinska M, Fan X, Zhu J, Yuan Z . PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis. Oncogene. 2016; 35(42):5527-5538. PMC: 5787860. DOI: 10.1038/onc.2016.93. View

Chang M, Azin M, Demehri S . Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention. Annu Rev Pathol. 2022; 17:101-119. DOI: 10.1146/annurev-pathol-042320-120056. View

Li Y, Zhang X . Therapeutic effects of ephrin B receptor 2 inhibitors screened by molecular docking on cutaneous squamous cell carcinoma. J Dermatolog Treat. 2020; 33(1):373-379. DOI: 10.1080/09546634.2020.1756201. View

Zhang L, Zhang J, Chen L, Wang J . Autophagy in human skin squamous cell carcinoma: Inhibition by 3-MA enhances the effect of 5-FU-induced chemotherapy sensitivity. Oncol Rep. 2015; 34(6):3147-55. DOI: 10.3892/or.2015.4302. View

Yang Y, Gao L, Chen J, Xiao W, Liu R, Kan H . Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma. Bioengineered. 2022; 13(4):9211-9231. PMC: 9161935. DOI: 10.1080/21655979.2022.2057896. View

10.

Ramirez C, Federman D, Kirsner R . Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol. 2005; 44(2):95-100. DOI: 10.1111/j.1365-4632.2005.02301.x. View

11.

Hedberg M, Berry C, Moshiri A, Xiang Y, Yeh C, Attilasoy C . Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma. Int J Mol Sci. 2022; 23(7). PMC: 8998533. DOI: 10.3390/ijms23073478. View

12.

Waldman A, Schmults C . Cutaneous Squamous Cell Carcinoma. Hematol Oncol Clin North Am. 2018; 33(1):1-12. DOI: 10.1016/j.hoc.2018.08.001. View

13.

Jung E, Lee W, Paramanantham A, Kim H, Shin S, Kim G . p53 Enhances L. Polyphenols-Induced Cell Death Through Upregulation of p53-Dependent Targets and Cleavage of PARP1 and Lamin A/C in HCT116 Colorectal Cancer Cells. Int J Mol Sci. 2020; 21(23). PMC: 7730414. DOI: 10.3390/ijms21239315. View

14.

Zhang L, Shan X, Chen Q, Xu D, Fan X, Yu M . Downregulation of HDAC3 by ginsenoside Rg3 inhibits epithelial-mesenchymal transition of cutaneous squamous cell carcinoma through c-Jun acetylation. J Cell Physiol. 2019; 234(12):22207-22219. DOI: 10.1002/jcp.28788. View

15.

Ci C, Wu C, Lyu D, Chang X, He C, Liu W . Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway. Clin Exp Dermatol. 2019; 45(2):194-201. DOI: 10.1111/ced.14072. View

16.

Wang J, Kondo T, Nakazawa T, Oishi N, Mochizuki K, Katoh R . Constitutional abnormality of nuclear membrane proteins in small cell lung carcinoma. Virchows Arch. 2019; 475(4):407-414. DOI: 10.1007/s00428-019-02597-7. View

17.

Tian K, Liu W, Zhang J, Fan X, Liu J, Zhao N . MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway. Cell Mol Biol Lett. 2020; 25:12. PMC: 7059386. DOI: 10.1186/s11658-020-00207-y. View

18.

Chu Z, Zhang X, Li Q, Hu G, Guo Lian C, Geng S . CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway. Int J Oncol. 2019; 54(5):1534-1544. PMC: 6438437. DOI: 10.3892/ijo.2019.4727. View

19.

Chen S, Zhang Y, Lei S, Zhou F . SASH1 Suppresses the Proliferation and Invasion of Human Skin Squamous Cell Carcinoma Cells via Inhibiting Akt Cascade. Onco Targets Ther. 2020; 13:4617-4625. PMC: 7259489. DOI: 10.2147/OTT.S234667. View

20.

Li F, Zhang C, Fu L . PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway. PLoS One. 2019; 14(10):e0218839. PMC: 6785111. DOI: 10.1371/journal.pone.0218839. View